2/23/2021Graviton Enters into Global Licensing Agreement for ROCK2 Inhibitor fr...

2/23/2021Review of Chinese Pharma Deals, R&D and Regulatory Developments in 202...

2/23/2021PharmaDJ's China Licensing Deals Tracker: Jan 2021

2/22/2021How Foreign Companies Can Break Into China's Biosimilar Market and Rel...

2/22/2021The Race to the Top: Does China Have What It Takes?

2/22/2021IHS Markit: China Pharma in the Year of the Ox

2/22/2021Anticancer Medicines in China: Trends in Daily Therapy Cost and Relati...

2/22/2021Junshi Bio Wins Chinese Conditional Approval for 2nd Indication for T...

2/22/2021AstraZeneca and HKSTP Launch Co-incubation Program for Oncology-relate...

2/20/2021CDE Solicits Comments on the Technical Requirements for Pharmaceutical...

2/20/2021Three Central Government Agencies Issue the Guidelines for Integrity o...

2/20/2021China Further Promotes TCM Development by Strengthening Scientific Res...

2/19/2021State Council Issues the Regulation on the Use of Medical Insurance Fu...

2/19/2021Recent Executive Moves

2/18/2021Junshi Bio Announces sNDA Acceptance for Toripalimab Combined with Ch...

2/18/20212020 Performance of Leading MNC Pharma Companies in China

2/17/2021Cend Therapeutics and Qilu Pharmaceutical Announce Partnership

2/17/2021Luye and Towa Enter Strategic Deal for Rivastigmine Multi-Day Transder...

2/17/2021Provention Bio and Huadong Announce Strategic Collaboration for PRV-32...

2/17/2021Scynexis and Hansoh Announce Licensing / Partnership Deal for Ibrexafu...

2/17/2021BeiGene Announces U.S. FDA Acceptance of sNDA for BRUKINSA (Zanubrutin...

2/17/2021BITT and BeiGene Enter Exclusive Option and License Deal to Develop No...

2/17/2021U.S. Chamber Releases In-Depth Analysis of U.S.-China Economic Relatio...

2/17/2021CDE Issues the Technical Guidelines for Similarity Assessment and Indi...

2/14/2021Adagene Completes $140M NASDAQ IPO

2/12/2021AstraZeneca Reports 2020 Performance, Highlighting China Challenges

2/12/2021Recent Executive Moves

2/10/2021CDE Issues Three Documents for Change Filings of Chemical Drugs and Bi...

2/9/2021NMPA Revises Packages Inserts of Thiamazole Formulations

2/9/2021NMPA Adds 72 Designated Core Laboratories to Support MedPharm Regulati...

Page:143/719 Total number of articles:21555: [First][<<] [141] [142] [143] [144] [145] [>>] [End]